Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals
- 3 December 2001
- Vol. 20 (5-6) , 905-913
- https://doi.org/10.1016/s0264-410x(01)00383-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Increased Plasma Human Immunodeficiency Virus Type 1 Burden following Antigenic Challenge with Pneumococcal VaccineThe Journal of Infectious Diseases, 1996
- T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaquesJournal of General Virology, 1996
- Lessons from the second AIDS virus, HIV-2AIDS, 1996
- Immune activation is a dominant factor in the pathogenesis of African AIDSImmunology Today, 1995
- Distinct alterations in the distribution of CD45RO+ T-cell subsets in HIV-2 compared with HIV-1 infection Ana C. JalecoAIDS, 1994
- Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patientsClinical and Experimental Immunology, 1994
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992
- Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patientsClinical and Experimental Immunology, 1991
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Revaccination against Tetanus 17 to 20 Years after Primary VaccinationPublished by Wolters Kluwer Health ,1987